| (USD) | Jun 2026 | Y/Y change |
|---|---|---|
| Revenue | 0.00 | — |
| Operating expense | — | — |
| Net income | -61.80M | — |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, MLTX returned -72.6% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | +16.3% |
| 1 year | -72.6% |
| 5 years | +55.2% |
| All-time high | $60.81 (Jul 2023) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what $1,000 in MLTX would be worth today ›No. MoonLake Immunotherapeutics has not paid a dividend in the past 12 months.
MoonLake Immunotherapeutics stock trades on NASDAQ under the ticker symbol MLTX.
MoonLake Immunotherapeutics is part of the Healthcare sector.
MoonLake Immunotherapeutics has a market cap of 1.30B USD, based on the latest quote.
MoonLake Immunotherapeutics is expected to report earnings around Nov 5, 2026. That date is an estimate and has not been confirmed by the company.
